Atlas Trials

UMIT-2 - Adaptive Phase IIb Platform Trial to Determine the Efficacy and Safety of Therapeutics for CCHF

Clinical trial NCT06860334 · RECRUITING

Trial details

NCT number
NCT06860334
Sponsor
Liverpool School of Tropical Medicine
Status
RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Crimean-Congo Hemorrhagic Fever
Start date
2026-06-04
Primary completion
2027-12-30
Enrollment
378

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.